$CRM
Salesforce, Inc. Stock $crm

$crm Overview Financials Valuation SEC Filings Company Website

2012 Q3 Form 10-Q Financial Statement

#000119312512377656 Filed on August 31, 2012

Income Statement

Concept	2012 Q3	2011 Q3	2011 Q2
Revenue	$731.6M	$546.0M	$504.4M
YoY Change	34.0%	38.44%	33.85%
Cost Of Revenue	$162.4M	$120.9M	$103.1M
YoY Change	34.33%	55.43%	43.99%
Gross Profit	$569.2M	$425.1M	$401.3M
YoY Change	33.91%	34.28%	31.49%
Gross Profit Margin	77.8%	77.86%	79.57%
Selling, General & Admin	$483.3M	$367.4M	$338.8M
YoY Change	31.52%	50.61%	46.0%
% of Gross Profit	84.9%	86.44%	84.43%
Research & Development	$99.44M	$73.39M	$65.29M
YoY Change	35.49%	70.96%	62.73%
% of Gross Profit	17.47%	17.27%	16.27%
Depreciation & Amortization	$50.00M	$40.20M	$29.60M
YoY Change	24.38%	125.84%	104.14%
% of Gross Profit	8.78%	9.46%	7.38%
Operating Expenses	$582.7M	$440.8M	$404.1M
YoY Change	32.18%	53.66%	48.47%
Operating Profit	-$13.47M	-$15.75M	-$2.803M
YoY Change	-14.49%	-153.06%	-108.49%
Interest Expense	$8.033M	$3.846M	$4.400M
YoY Change	108.87%	140.38%	450.0%
% of Operating Profit
Other Income/Expense, Net	$294.0K	-$3.231M	-$800.0K
YoY Change	-109.1%	79.5%	-60.0%
Pretax Income	-$14.03M	-$17.71M	$800.0K
YoY Change	-20.78%	-160.04%	-97.49%
Income Tax	-$4.203M	-$13.45M	$300.0K
% Of Pretax Income			37.5%
Net Earnings	-$9.829M	-$4.268M	$530.0K
YoY Change	130.3%	-129.03%	-97.01%
Net Earnings / Revenue	-1.34%	-0.78%	0.11%
Basic Earnings Per Share	-$0.02	-$0.03	$0.00
Diluted Earnings Per Share	-$0.02	-$0.03	$0.00
COMMON SHARES
Basic Shares Outstanding	557.7M shares	135.1M shares	133.5M
Diluted Shares Outstanding	557.7M shares	135.1M shares

Balance Sheet

Concept	2012 Q3	2011 Q3	2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.804B	$577.0M	$764.0M
YoY Change	212.7%	-22.24%	-19.75%
Cash & Equivalents	$1.001B	$449.8M	$664.6M
Short-Term Investments	$803.5M	$128.0M	$99.00M
Other Short-Term Assets	$298.0M	$195.0M	$153.0M
YoY Change	52.82%	38.3%	18.6%
Inventory
Prepaid Expenses	$146.9M
Receivables	$446.9M	$342.0M	$271.0M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.853B	$1.115B	$1.188B
YoY Change	66.2%	0.27%	-6.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$556.8M	$470.0M	$446.0M
YoY Change	18.46%	365.35%	412.64%
Goodwill	$840.5M
YoY Change
Intangibles	$41.31M
YoY Change
Long-Term Investments	$748.0M	$750.0M	$790.0M
YoY Change	-0.27%	-33.27%	-17.36%
Other Assets	$148.0M	$156.0M	$136.0M
YoY Change	-5.1%	57.58%	47.83%
Total Long-Term Assets	$2.600B	$2.306B	$1.940B
YoY Change	12.77%	45.4%	58.5%
TOTAL ASSETS
Total Short-Term Assets	$1.853B	$1.115B	$1.188B
Total Long-Term Assets	$2.600B	$2.306B	$1.940B
Total Assets	$4.454B	$3.421B	$3.128B
YoY Change	30.18%	26.8%	25.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$69.34M	$22.00M	$17.00M
YoY Change	215.18%	4.76%	30.77%
Accrued Expenses	$482.9M	$390.0M	$296.0M
YoY Change	23.82%	59.18%	66.29%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$509.0M	$484.0M	$478.0M
YoY Change	5.17%
Total Short-Term Liabilities	$2.329B	$1.814B	$1.685B
YoY Change	28.4%	95.26%	101.07%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities	$185.0M	$154.0M	$167.0M
YoY Change	20.13%	340.0%	475.86%
Total Long-Term Liabilities	$185.0M	$154.0M	$167.0M
YoY Change	20.13%	-68.95%	-65.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.329B	$1.814B	$1.685B
Total Long-Term Liabilities	$185.0M	$154.0M	$167.0M
Total Liabilities	$2.495B	$2.003B	$1.872B
YoY Change	24.56%	37.38%	38.26%
SHAREHOLDERS EQUITY
Retained Earnings	$130.2M
YoY Change
Common Stock	$139.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.892B	$1.418B	$1.256B
YoY Change
Total Liabilities & Shareholders Equity	$4.454B	$3.421B	$3.128B
YoY Change	30.18%	26.8%	25.72%

Cashflow Statement

Concept	2012 Q3	2011 Q3	2011 Q2
OPERATING ACTIVITIES
Net Income	-$9.829M	-$4.268M	$530.0K
YoY Change	130.3%	-129.03%	-97.01%
Depreciation, Depletion And Amortization	$50.00M	$40.20M	$29.60M
YoY Change	24.38%	125.84%	104.14%
Cash From Operating Activities	$136.2M	$82.93M	$139.5M
YoY Change	64.23%	8.98%	-2.58%
INVESTING ACTIVITIES
Capital Expenditures	$29.30M	$45.05M	-$27.30M
YoY Change	-34.95%	-262.05%	133.33%
Acquisitions	$10.08M	$285.3M
YoY Change	-96.47%
Other Investing Activities	$401.6M	-$276.9M	$106.7M
YoY Change	-245.03%	-28.56%	-121.49%
Cash From Investing Activities	$372.3M	-$321.9M	$79.40M
YoY Change	-215.64%	-22.5%	-115.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	41.05M	20.42M	28.00M
YoY Change	101.02%	-62.81%	-35.78%
NET CHANGE
Cash From Operating Activities	136.2M	82.93M	139.5M
Cash From Investing Activities	372.3M	-321.9M	79.40M
Cash From Financing Activities	41.05M	20.42M	28.00M
Net Change In Cash	549.5M	-218.6M	246.9M
YoY Change	-351.41%	-23.14%	-176.84%
FREE CASH FLOW
Cash From Operating Activities	$136.2M	$82.93M	$139.5M
Capital Expenditures	$29.30M	$45.05M	-$27.30M
Free Cash Flow	$106.9M	$37.88M	$166.8M
YoY Change	182.17%	-63.54%	7.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2010Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	23300000
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	664612000
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	449794000
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	440785000
CY2012Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	139000000	shares
CY2012Q3	us-gaap	Goodwill Goodwill	840531000
CY2012Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	123269000
CY2012Q3	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	4813000
CY2012Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	90468000
CY2012Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	49572000
CY2012Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	756575000
CY2012Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	574890000
CY2012Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	56723000
CY2012Q3	us-gaap	Acquired Finite Lived Intangible Asset Amount AcquiredFiniteLivedIntangibleAssetAmount	15841000
CY2012Q3	us-gaap	Business Acquisition Purchase Price Allocation Net Tangible Assets BusinessAcquisitionPurchasePriceAllocationNetTangibleAssets	758000
CY2012Q3	us-gaap	Deferred Costs Current DeferredCostsCurrent	7825000
CY2012Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	148039000
CY2012Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0075	pure
CY2012Q3	us-gaap	Stockholders Equity StockholdersEquity	1892314000
CY2012Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1000
CY2012Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	62588000
CY2012Q3	us-gaap	Other Assets OtherAssets	24217000
CY2012Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	797243000
CY2012Q3	us-gaap	Business Acquisition Purchase Price Allocation Assets Acquired Liabilities Assumed Net BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet	50636000
CY2012Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	696602000
CY2012Q3	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2	507000
CY2012Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	150149000
CY2012Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	88.46
CY2012Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	297287000
CY2012Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	49790000
CY2012Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	85.36
CY2012Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	9852093	shares
CY2012Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	192776000
CY2012Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	66357000
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	61.87
CY2012Q3	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses2	1064000
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	413350000
CY2012Q3	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Amount BusinessAcquisitionPurchasePriceAllocationGoodwillAmount	45579000
CY2012Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	24026000
CY2012Q3	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	61638000
CY2012Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	75727000
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	4478241	shares
CY2012Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	123035000
CY2012Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	93697000
CY2012Q3	us-gaap	Accrued Rent Current AccruedRentCurrent	47418000
CY2012Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	106933000
CY2012Q3	us-gaap	Liabilities Liabilities	2494899000
CY2012Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	69339000
CY2012Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	146901000
CY2012Q3	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	8908000
CY2012Q3	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	119300000
CY2012Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1268407000
CY2012Q3	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	47165000
CY2012Q3	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	65265000
CY2012Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	108031000
CY2012Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	130159000
CY2012Q3	us-gaap	Assets Assets	4453570000
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	88.46
CY2012Q3	us-gaap	Other Long Term Investments OtherLongTermInvestments	51276000
CY2012Q3	us-gaap	Deferred Costs DeferredCosts	2101000
CY2012Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	51100000
CY2012Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	13293000
CY2012Q3	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	5615000
CY2012Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	446917000
CY2012Q3	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	7356000
CY2012Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4453570000
CY2012Q3	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	29448000
CY2012Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	148470000
CY2012Q3	us-gaap	Foreign Currency Derivatives At Fair Value Net ForeignCurrencyDerivativesAtFairValueNet	-419000
CY2012Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	32567000
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	411390000
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1000730000
CY2012Q3	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	66357000
CY2012Q3	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	1064000
CY2012Q3	us-gaap	Notional Amount Of Foreign Currency Derivatives NotionalAmountOfForeignCurrencyDerivatives	417890000
CY2012Q3	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	3627000
CY2012Q3	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	1030000
CY2012Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	6735953	shares
CY2012Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	41311000
CY2012Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	297893000
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	9650899	shares
CY2012Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	19730000
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	5335606	shares
CY2012Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	36265444	shares
CY2012Q3	us-gaap	Business Acquisition Purchase Price Allocation Amortizable Intangible Assets BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets	5970000
CY2012Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	482888000
CY2012Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	29402000
CY2012Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	321100000
CY2012Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure	46900000
CY2012Q3	us-gaap	Marketable Securities MarketableSecurities	803535000
CY2012Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2329167000
CY2012Q3	us-gaap	Deferred Revenue DeferredRevenue	17400000
CY2012Q3	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2	557000
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9852093	shares
CY2012Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	173456000
CY2012Q3	us-gaap	Common Stock Value CommonStockValue	139000
CY2012Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	68777000
CY2012Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	508533000
CY2012Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	68519000
CY2012Q3	us-gaap	Land Land	248263000
CY2012Q3	us-gaap	Assets Current AssetsCurrent	1853125000
CY2012Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	508533000
CY2012Q3	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	9900000
CY2012Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	722502000
CY2012Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	199799000
CY2012Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	556776000
CY2012Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1742286000
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	87.71
CY2012Q3	us-gaap	Business Acquisition Purchase Price Allocation Deferred Income Taxes Asset Liability Net BusinessAcquisitionPurchasePriceAllocationDeferredIncomeTaxesAssetLiabilityNet	-1671000
CY2012Q3	crm	Deferred Commissions Current DeferredCommissionsCurrent	94921000
CY2012Q3	crm	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestAggregateIntrinsicValue	642447000
CY2012Q3	crm	Capitalized Preproduction And Construction Recoverable Costs CapitalizedPreproductionAndConstructionRecoverableCosts	5700000
CY2012Q3	crm	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingNumber	5335606	shares
CY2012Q3	crm	Shares Available For Grant SharesAvailableForGrant	5945434	shares
CY2012Q3	crm	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	0.001
CY2012Q3	crm	Sharebased Compensation Arrangement By Sharebased Payment Award In Period Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardInPeriodExercisePrice	0.00
CY2012Q3	crm	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingNumber	4478241	shares
CY2012Q3	crm	Computers Equipment And Software ComputersEquipmentAndSoftware	280868000
CY2012Q3	crm	Value Of Resources Donated To Related Parties ValueOfResourcesDonatedToRelatedParties	150000
CY2012Q3	crm	Business Acquisition Fair Value Of Stock Award Allocated For Future Services BusinessAcquisitionFairValueOfStockAwardAllocatedForFutureServices	1700000
CY2012Q3	crm	Common Stock Shares Held By Related Parties CommonStockSharesHeldByRelatedParties	88500	shares
CY2012Q3	crm	Fair Value Of Assumed Stock Awards Allocated To Purchase Price Of Business Combination FairValueOfAssumedStockAwardsAllocatedToPurchasePriceOfBusinessCombination	500000
CY2012Q3	crm	Significant Concentration Of Accounts Receivable Number Customers SignificantConcentrationOfAccountsReceivableNumberCustomers	0	pure
CY2012Q3	crm	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice	0.001
CY2012Q3	crm	Accumulated Amortization Relating To Computers Equipment And Software Under Capital Leases AccumulatedAmortizationRelatingToComputersEquipmentAndSoftwareUnderCapitalLeases	43100000
CY2012Q3	crm	Restricted Stock Units Vesting Period RestrictedStockUnitsVestingPeriod	4	Year
CY2012Q3	crm	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value In Dollars ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValueInDollars	663536000
CY2012Q3	crm	Deferred Commission Noncurrent DeferredCommissionNoncurrent	77010000
CY2012Q3	crm	Prepaid Expenses And Other Current Assets PrepaidExpensesAndOtherCurrentAssets	115069000
CY2012Q3	crm	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber	5166030	shares
CY2012Q3	crm	Shares Reserved In Employee Stock Incentive Plan SharesReservedInEmployeeStockIncentivePlan	30177	shares
CY2012Q3	crm	Options Granted During Period OptionsGrantedDuringPeriod	733592	shares
CY2012Q3	crm	Shares Available For Grant Cancelled During Period SharesAvailableForGrantCancelledDuringPeriod	288334	shares
CY2012Q3	crm	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageExercisePrice	61.87
CY2012Q3	crm	Prepaid Income Taxes PrepaidIncomeTaxes	24007000
CY2012Q3	crm	Increase In Options Authorized Under2006 Equity Inducement Plan IncreaseInOptionsAuthorizedUnder2006EquityInducementPlan	400000	shares
CY2012Q3	crm	Business Acquisition Purchase Price Allocation Stock Options Assumed Amount BusinessAcquisitionPurchasePriceAllocationStockOptionsAssumedAmount	2200000
CY2012Q3	crm	Capital Leases Future Minimum Payments Due For Remaining Fiscal Year Period CapitalLeasesFutureMinimumPaymentsDueForRemainingFiscalYearPeriod	15451000
CY2012Q3	crm	Operating Leases Future Minimum Payments Due For Remaining Fiscal Year Period OperatingLeasesFutureMinimumPaymentsDueForRemainingFiscalYearPeriod	69328000
CY2010Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	574890000
CY2010Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	126500000
CY2010Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0075	pure
CY2010Q1	us-gaap	Deferred Tax Assets Hedging Transactions DeferredTaxAssetsHedgingTransactions	51400000
CY2010Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	6700000	shares
CY2010Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	119.51
CY2011Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	424292000
CY2012Q1	us-gaap	Goodwill Goodwill	785381000
CY2012Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	43868000
CY2012Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	687428000
CY2012Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	574890000
CY2012Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	31821000
CY2012Q1	us-gaap	Acquired Finite Lived Intangible Asset Amount AcquiredFiniteLivedIntangibleAssetAmount	15020000
CY2012Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	10399000
CY2012Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	155149000
CY2012Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0075	pure
CY2012Q1	us-gaap	Stockholders Equity StockholdersEquity	1587360000
CY2012Q1	us-gaap	Other Assets OtherAssets	22194000
CY2012Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	835519000
CY2012Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	669308000
CY2012Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	121957000
CY2012Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	48651000
CY2012Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	85.36
CY2012Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	228466000
CY2012Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	78741000
CY2012Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	21993000
CY2012Q1	us-gaap	Accrued Rent Current AccruedRentCurrent	29555000
CY2012Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	170582000
CY2012Q1	us-gaap	Liabilities Liabilities	2498053000
CY2012Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	33258000
CY2012Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	80319000
CY2012Q1	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	105100000
CY2012Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1291622000
CY2012Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	37258000
CY2012Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	87587000
CY2012Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	159463000
CY2012Q1	us-gaap	Assets Assets	4164154000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	79.78
CY2012Q1	us-gaap	Other Long Term Investments OtherLongTermInvestments	53949000
CY2012Q1	us-gaap	Deferred Costs DeferredCosts	3935000
CY2012Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	13941000
CY2012Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	683745000
CY2012Q1	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	6578000
CY2012Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4164154000
CY2012Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	137587000
CY2012Q1	us-gaap	Foreign Currency Derivatives At Fair Value Net ForeignCurrencyDerivativesAtFairValueNet	-1930000
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	607284000
CY2012Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	78741000
CY2012Q1	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	2207000
CY2012Q1	us-gaap	Notional Amount Of Foreign Currency Derivatives NotionalAmountOfForeignCurrencyDerivatives	186336000
CY2012Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	46110000
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	12683000
CY2012Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	502442000
CY2012Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	25250000
CY2012Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure	48300000
CY2012Q1	us-gaap	Marketable Securities MarketableSecurities	839890000
CY2012Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2323471000
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11184907	shares
CY2012Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	188412000
CY2012Q1	us-gaap	Common Stock Value CommonStockValue	137000
CY2012Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	88673000
CY2012Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	496149000
CY2012Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	100471000
CY2012Q1	us-gaap	Land Land	248263000
CY2012Q1	us-gaap	Assets Current AssetsCurrent	1672222000
CY2012Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	496149000
CY2012Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	159482000
CY2012Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	527946000
CY2012Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1415077000
CY2012Q1	crm	Deferred Commissions Current DeferredCommissionsCurrent	98471000
CY2012Q1	crm	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingNumber	4962263	shares
CY2012Q1	crm	Shares Available For Grant SharesAvailableForGrant	3440993	shares
CY2012Q1	crm	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	0.001
CY2012Q1	crm	Computers Equipment And Software ComputersEquipmentAndSoftware	232460000
CY2012Q1	crm	Accumulated Amortization Relating To Computers Equipment And Software Under Capital Leases AccumulatedAmortizationRelatingToComputersEquipmentAndSoftwareUnderCapitalLeases	31700000
CY2012Q1	crm	Deferred Commission Noncurrent DeferredCommissionNoncurrent	78149000
CY2012Q1	crm	Prepaid Expenses And Other Current Assets PrepaidExpensesAndOtherCurrentAssets	57135000
CY2012Q1	crm	Significant Concentration Of Accounts Receivable Number Customers SignificantConcentrationOfAccountsReceivableNumberCustomers	1	pure
CY2012Q1	crm	Prepaid Income Taxes PrepaidIncomeTaxes	12785000
CY2012Q1	us-gaap	Business Acquisition Cost Of Acquired Entity Equity Interests Issued And Issuable BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable	470000
CY2012Q1	us-gaap	Business Acquisition Cost Of Acquired Entity Cash Paid BusinessAcquisitionCostOfAcquiredEntityCashPaid	50166000
CY2012Q1	us-gaap	Business Acquisition Cost Of Acquired Entity Purchase Price BusinessAcquisitionCostOfAcquiredEntityPurchasePrice	50636000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	169600000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18551000
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	34600000
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	1526000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2984000
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1026000
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	298670000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4031000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3238000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	18735000
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	31500000
	us-gaap	Share Based Compensation ShareBasedCompensation	102152000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Profit Loss ProfitLoss	-3738000
	us-gaap	Investment Income Net InvestmentIncomeNet	13167000
	us-gaap	Debt Instrument Convertible Effective Interest Rate DebtInstrumentConvertibleEffectiveInterestRate	0.0586	pure
	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	16200000
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	69832000
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.78	pure
	us-gaap	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	800000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	222451000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-242566000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	11518000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-355000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	72365000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	25502000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	168784000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4626000
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	74568000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	143.59
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	134273000	shares
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4332000
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-90051000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-16932000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	537472000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	500000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	138685000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	48377000
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	18994000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	2745000
	us-gaap	Cost Of Revenue CostOfRevenue	223976000
	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	49591000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-1219000
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	307564000
	us-gaap	Operating Expenses OperatingExpenses	844941000
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	4120000
	us-gaap	Cost Of Services CostOfServices	59589000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	134273000	shares
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
	us-gaap	Revenues Revenues	1050366000
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	67583000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12006000
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	46641000
	us-gaap	Gross Profit GrossProfit	826390000
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	436949000
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	14111000
	us-gaap	Interest Paid InterestPaid	3086000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	11690000
	us-gaap	Net Income Loss NetIncomeLoss	-3738000
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	4120000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-13194000
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-2760000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3500000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-18017000
	us-gaap	Interest Expense InterestExpense	7517000
	us-gaap	Debt Instrument Convertible Interest Expense DebtInstrumentConvertibleInterestExpense	14507000
	crm	Subscription And Support Revenue SubscriptionAndSupportRevenue	982783000
	crm	Cost Of Revenue Subscription And Support CostOfRevenueSubscriptionAndSupport	164387000
	crm	Supplemental Assets Acquired Under Capital Leases SupplementalAssetsAcquiredUnderCapitalLeases	47203000
	crm	Noncash Or Part Noncash Acquisition Stock Acquired NoncashOrPartNoncashAcquisitionStockAcquired	4729000
	crm	Amortization Of Debt Issuance Costs AmortizationOfDebtIssuanceCosts	661000
	crm	Percentage Of Customer Total Revenue Required To Be Considered Significant Customer PercentageOfCustomerTotalRevenueRequiredToBeConsideredSignificantCustomer	0.05	pure
	crm	Land Activity And Building Improvements LandActivityAndBuildingImprovements	6436000
	crm	Total Investment Income TotalInvestmentIncome	13167000
	crm	Stock Based Compensation Expense Associated With Cost Of Revenue StockBasedCompensationExpenseAssociatedWithCostOfRevenue	8030000
	crm	Amortization Of Purchased Intangibles Associated With Cost Of Revenues AmortizationOfPurchasedIntangiblesAssociatedWithCostOfRevenues	25468000
	crm	Significant Concentration Of Total Revenue Number Customers SignificantConcentrationOfTotalRevenueNumberCustomers	0	pure
	crm	Cash Cash Equivalents And Marketable Securities Realized Loss CashCashEquivalentsAndMarketableSecuritiesRealizedLoss	2124000
	crm	Contractual Interest Expense ContractualInterestExpense	2156000
	crm	Stock Based Compensation Expense Associated With General And Administrative Expenses StockBasedCompensationExpenseAssociatedWithGeneralAndAdministrativeExpenses	24194000
	crm	Payments For Investments In Privately Held Companies PaymentsForInvestmentsInPrivatelyHeldCompanies	13215000
	crm	Stock Based Compensation Expense Associated With Sales And Marketing Expenses StockBasedCompensationExpenseAssociatedWithSalesAndMarketingExpenses	50901000
	crm	Stock Based Compensation Expense Associated With Research And Development Expenses StockBasedCompensationExpenseAssociatedWithResearchAndDevelopmentExpenses	19027000
	crm	Amortization Of Purchased Intangibles Associated With Sales And Marketing Expense AmortizationOfPurchasedIntangiblesAssociatedWithSalesAndMarketingExpense	3546000
	crm	Cash Cash Equivalents And Marketable Securities Realized Gain CashCashEquivalentsAndMarketableSecuritiesRealizedGain	3773000
	dei	Trading Symbol TradingSymbol	CRM
	dei	Entity Registrant Name EntityRegistrantName	SALESFORCE COM INC
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2012-07-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001108524
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	166000000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-35715000
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	51600000
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	7106000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	36081000
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	59000
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	58991000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-416000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22257000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	84887000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1187736	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y10M24D
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	45700000
	us-gaap	Share Based Compensation ShareBasedCompensation	166683000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	137.88
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	99.69
	us-gaap	Profit Loss ProfitLoss	-29304000
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1778072	shares
	us-gaap	Investment Income Net InvestmentIncomeNet	11634000
	us-gaap	Debt Instrument Convertible Effective Interest Rate DebtInstrumentConvertibleEffectiveInterestRate	0.0586	pure
	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	0
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	99440000
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.25	pure
	us-gaap	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	2000000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	349409000
	us-gaap	Fiscal Period FiscalPeriod	<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Fiscal Year</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company’s fiscal year ends on January 31. References to fiscal 2013, for example, refer to the fiscal year ending January 31, 2013.</font></p> </div>
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-102701000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9664000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-43111000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	576525	shares
	us-gaap	Debt Instrument Convertible Remaining Discount Amortization Period1 DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1	P2Y6M
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	52.39
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	74025000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	393446000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	204695000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-864000
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	127391000
	us-gaap	Debt Instrument Convertible Conversion Ratio DebtInstrumentConvertibleConversionRatio	11.7147	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	142.16
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	138789000	shares
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	11040000
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y10M24D
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-237138000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-38900000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	749949000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7047000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	194218000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	138083000
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	56096000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	159000
	us-gaap	Cost Of Revenue CostOfRevenue	313969000
	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	72029000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	6947000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	288334	shares
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	594904000
	us-gaap	Operating Expenses OperatingExpenses	1148862000
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	25745000
	us-gaap	Cost Of Services CostOfServices	86706000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	138789000	shares
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y
	us-gaap	Revenues Revenues	1427116000
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	84403000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	45467000
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	67340000
	us-gaap	Gross Profit GrossProfit	1113147000
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	548232000
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	15053000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
	us-gaap	Interest Paid InterestPaid	3390000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	12384000
	crm	Shares Covered By Note Hedges SharesCoveredByNoteHedges	6700000	shares
	crm	Stock Based Compensation Expense Associated With Cost Of Revenue StockBasedCompensationExpenseAssociatedWithCostOfRevenue	15117000
	crm	Prior Contractual Life Of Stock Options In Years PriorContractualLifeOfStockOptionsInYears	10	Year
	us-gaap	Net Income Loss NetIncomeLoss	-29304000
	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	576525	shares
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	25745000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9596000
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	8655000
	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Use of Estimates</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions in the Company’s condensed consolidated financial statements and notes thereto.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Significant estimates and assumptions made by management include the determination of:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1"> </font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">the best estimate of selling price of the deliverables included in multiple-deliverable revenue arrangements,</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1"> </font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">the fair value of assets acquired and liabilities assumed for business combinations,</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1"> </font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">recognition and measurement of current and deferred income taxes,</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1"> </font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">the fair value of stock awards issued, and</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1"> </font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">the valuation of strategic investments and the determination of other-than-temporary impairments.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Actual results could differ materially from those estimates.</font></p> </div>
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5800000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	237868	shares
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	9571000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-52270000
	us-gaap	Interest Expense InterestExpense	14403000
	us-gaap	Debt Instrument Convertible Interest Expense DebtInstrumentConvertibleInterestExpense	15202000
	crm	Share Based Compensation Arrangement By Share Based Payment Award Conversion Ratio ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRatio	0.011	pure
	crm	Subscription And Support Revenue SubscriptionAndSupportRevenue	1342713000
	crm	Cost Of Revenue Subscription And Support CostOfRevenueSubscriptionAndSupport	227263000
	crm	Supplemental Assets Acquired Under Capital Leases SupplementalAssetsAcquiredUnderCapitalLeases	15797000
	crm	Estimated Unrecognized Tax Benefits Period Increase Decrease EstimatedUnrecognizedTaxBenefitsPeriodIncreaseDecrease	4000000
	crm	Noncash Or Part Noncash Acquisition Stock Acquired NoncashOrPartNoncashAcquisitionStockAcquired	2204000
	crm	Amortization Of Debt Issuance Costs AmortizationOfDebtIssuanceCosts	662000
	crm	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice	0.001
	crm	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice	0.001
	crm	Percentage Of Assets Outside Of Americas PercentageOfAssetsOutsideOfAmericas	0.12	pure
	crm	Fair Value Of Donated Warrants To Related Parties FairValueOfDonatedWarrantsToRelatedParties	3100000
	crm	Total Investment Income TotalInvestmentIncome	11634000
	crm	Convertible Senior Notes Shares ConvertibleSeniorNotesShares	6734664	shares
	crm	Percentage Of Customer Total Revenue Required To Be Considered Significant Customer PercentageOfCustomerTotalRevenueRequiredToBeConsideredSignificantCustomer	0.05	pure
	crm	Notes Trading Price Percentage NotesTradingPricePercentage	0.98	pure
	crm	Contractual Life Of Stock Options In Years ContractualLifeOfStockOptionsInYears	5	Year
	crm	Land Activity And Building Improvements LandActivityAndBuildingImprovements	4106000
	crm	Percentage Of Customer Accounts Receivable Required To Be Considered Significant Customer PercentageOfCustomerAccountsReceivableRequiredToBeConsideredSignificantCustomer	0.05	pure
	crm	Shares Available For Grant Exercised SharesAvailableForGrantExercised	0	shares
	crm	Amortization Of Purchased Intangibles Associated With Cost Of Revenues AmortizationOfPurchasedIntangiblesAssociatedWithCostOfRevenues	35116000
	crm	Significant Concentration Of Total Revenue Number Customers SignificantConcentrationOfTotalRevenueNumberCustomers	0	pure
	crm	Cash Cash Equivalents And Marketable Securities Realized Loss CashCashEquivalentsAndMarketableSecuritiesRealizedLoss	1584000
	crm	Contractual Interest Expense ContractualInterestExpense	2156000
	crm	Stock Based Compensation Expense Associated With General And Administrative Expenses StockBasedCompensationExpenseAssociatedWithGeneralAndAdministrativeExpenses	33042000
	crm	Payments For Investments In Privately Held Companies PaymentsForInvestmentsInPrivatelyHeldCompanies	3794000
	crm	Stock Based Compensation Expense Associated With Sales And Marketing Expenses StockBasedCompensationExpenseAssociatedWithSalesAndMarketingExpenses	86768000
	crm	Percentage Of Purchase Price Of Notes Which Should Be Paid Upon Fundamental Change PercentageOfPurchasePriceOfNotesWhichShouldBePaidUponFundamentalChange	1.00	pure
	crm	Stock Based Compensation Expense Associated With Research And Development Expenses StockBasedCompensationExpenseAssociatedWithResearchAndDevelopmentExpenses	31756000
	crm	Amortization Of Purchased Intangibles Associated With Sales And Marketing Expense AmortizationOfPurchasedIntangiblesAssociatedWithSalesAndMarketingExpense	5834000
	crm	Cash Cash Equivalents And Marketable Securities Realized Gain CashCashEquivalentsAndMarketableSecuritiesRealizedGain	3554000
	crm	Number Of Reportable Operating Segments NumberOfReportableOperatingSegments	1	Segment
CY2010Q4	crm	Number Of Acquired Acres Of Land NumberOfAcquiredAcresOfLand	14	acre
CY2010Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	59300000
CY2010Q1	crm	Shares Of Common Stock Covered By Note Hedges SharesOfCommonStockCoveredByNoteHedges	6700000	shares
CY2012	crm	Percentage Of Customer Accounts Receivable Required To Be Considered Significant Customer PercentageOfCustomerAccountsReceivableRequiredToBeConsideredSignificantCustomer	0.06	pure
CY2012	crm	Percentage Of Assets Outside Of Americas PercentageOfAssetsOutsideOfAmericas	0.13	pure
CY2011Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-15748000
CY2011Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	7910000
CY2011Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4121000
CY2011Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	767000
CY2011Q3	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	285335000
CY2011Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3231000
CY2011Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2875000
CY2011Q3	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	12220000
CY2011Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2011Q3	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	13400000
CY2011Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2011Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	40239000
CY2011Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	16700000
CY2011Q3	us-gaap	Share Based Compensation ShareBasedCompensation	54594000
CY2011Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2011Q3	us-gaap	Profit Loss ProfitLoss	-4268000
CY2011Q3	us-gaap	Investment Income Net InvestmentIncomeNet	5112000
CY2011Q3	us-gaap	Debt Instrument Convertible Effective Interest Rate DebtInstrumentConvertibleEffectiveInterestRate	0.0586	pure
CY2011Q3	us-gaap	Net Income Loss NetIncomeLoss	-4268000
CY2011Q3	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	2086000
CY2011Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-13445000
CY2011Q3	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	3758000
CY2011Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2300000
CY2011Q3	us-gaap	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	500000
CY2011Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	82933000
CY2011Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-321928000
CY2011Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	5255000
CY2011Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	19453000
CY2011Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45051000
CY2011Q3	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-214818000
CY2011Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	84446000
CY2011Q3	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1913000
CY2011Q3	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	42282000
CY2011Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	135093000	shares
CY2011Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2077000
CY2011Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2011Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	66076000
CY2011Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17713000
CY2011Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	283001000
CY2011Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7143000
CY2011Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2011Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	73393000
CY2011Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20419000
CY2011Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	9611000
CY2011Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	2052000
CY2011Q3	us-gaap	Cost Of Revenue CostOfRevenue	120910000
CY2011Q3	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	24916000
CY2011Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	5858000
CY2011Q3	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	75437000
CY2011Q3	us-gaap	Operating Expenses OperatingExpenses	440840000
CY2011Q3	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	2086000
CY2011Q3	us-gaap	Cost Of Services CostOfServices	31766000
CY2011Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	135093000	shares
CY2011Q3	us-gaap	Revenues Revenues	546002000
CY2011Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	36723000
CY2011Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1028000
CY2011Q3	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	26137000
CY2011Q3	us-gaap	Gross Profit GrossProfit	425092000
CY2011Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	84879000
CY2011Q3	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	10549000
CY2011Q3	us-gaap	Interest Paid InterestPaid	2749000
CY2011Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5859000
CY2011Q3	crm	Subscription And Support Revenue SubscriptionAndSupportRevenue	509279000
CY2011Q3	crm	Cost Of Revenue Subscription And Support CostOfRevenueSubscriptionAndSupport	89144000
CY2011Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	47624000
CY2011Q3	us-gaap	Interest Expense InterestExpense	3846000
CY2011Q3	us-gaap	Debt Instrument Convertible Interest Expense DebtInstrumentConvertibleInterestExpense	7268000
CY2011Q3	crm	Supplemental Assets Acquired Under Capital Leases SupplementalAssetsAcquiredUnderCapitalLeases	0
CY2011Q3	crm	Noncash Or Part Noncash Acquisition Stock Acquired NoncashOrPartNoncashAcquisitionStockAcquired	4729000
CY2011Q3	crm	Amortization Of Debt Issuance Costs AmortizationOfDebtIssuanceCosts	331000
CY2011Q3	crm	Percentage Of Customer Total Revenue Required To Be Considered Significant Customer PercentageOfCustomerTotalRevenueRequiredToBeConsideredSignificantCustomer	0.05	pure
CY2011Q3	crm	Land Activity And Building Improvements LandActivityAndBuildingImprovements	5422000
CY2011Q3	crm	Total Investment Income TotalInvestmentIncome	5112000
CY2011Q3	crm	Stock Based Compensation Expense Associated With Cost Of Revenue StockBasedCompensationExpenseAssociatedWithCostOfRevenue	4379000
CY2011Q3	crm	Amortization Of Purchased Intangibles Associated With Cost Of Revenues AmortizationOfPurchasedIntangiblesAssociatedWithCostOfRevenues	16373000
CY2011Q3	crm	Significant Concentration Of Total Revenue Number Customers SignificantConcentrationOfTotalRevenueNumberCustomers	0	pure
CY2011Q3	crm	Cash Cash Equivalents And Marketable Securities Realized Loss CashCashEquivalentsAndMarketableSecuritiesRealizedLoss	645000
CY2011Q3	crm	Contractual Interest Expense ContractualInterestExpense	1078000
CY2011Q3	crm	Stock Based Compensation Expense Associated With General And Administrative Expenses StockBasedCompensationExpenseAssociatedWithGeneralAndAdministrativeExpenses	11913000
CY2011Q3	crm	Payments For Investments In Privately Held Companies PaymentsForInvestmentsInPrivatelyHeldCompanies	7782000
CY2011Q3	crm	Stock Based Compensation Expense Associated With Sales And Marketing Expenses StockBasedCompensationExpenseAssociatedWithSalesAndMarketingExpenses	27114000
CY2011Q3	crm	Stock Based Compensation Expense Associated With Research And Development Expenses StockBasedCompensationExpenseAssociatedWithResearchAndDevelopmentExpenses	11188000
CY2011Q3	crm	Amortization Of Purchased Intangibles Associated With Sales And Marketing Expense AmortizationOfPurchasedIntangiblesAssociatedWithSalesAndMarketingExpense	2306000
CY2011Q3	crm	Cash Cash Equivalents And Marketable Securities Realized Gain CashCashEquivalentsAndMarketableSecuritiesRealizedGain	502000
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-13466000
CY2012Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	9174000
CY2012Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	49586000
CY2012Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-359000
CY2012Q3	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	10078000
CY2012Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	294000
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-296000
CY2012Q3	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	47188000
CY2012Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2012Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	23300000
CY2012Q3	us-gaap	Share Based Compensation ShareBasedCompensation	85417000
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2012Q3	us-gaap	Profit Loss ProfitLoss	-9829000
CY2012Q3	us-gaap	Investment Income Net InvestmentIncomeNet	7173000
CY2012Q3	us-gaap	Debt Instrument Convertible Effective Interest Rate DebtInstrumentConvertibleEffectiveInterestRate	0.0586	pure
CY2012Q3	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	0
CY2012Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2012Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	49999000
CY2012Q3	us-gaap	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	800000
CY2012Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	136197000
CY2012Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	372286000
CY2012Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	4915000
CY2012Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2469000
CY2012Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29304000
CY2012Q3	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	559945000
CY2012Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	103095000
CY2012Q3	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	891000
CY2012Q3	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	33824000
CY2012Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139425000	shares
CY2012Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6371000
CY2012Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2012Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	75522000
CY2012Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-14032000
CY2012Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	380160000
CY2012Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	9533000
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2012Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	99442000
CY2012Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	41047000
CY2012Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	35747000
CY2012Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-961000
CY2012Q3	us-gaap	Cost Of Revenue CostOfRevenue	162418000
CY2012Q3	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	35783000
CY2012Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	10135000
CY2012Q3	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	107101000
CY2012Q3	us-gaap	Operating Expenses OperatingExpenses	582697000
CY2012Q3	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	14702000
CY2012Q3	us-gaap	Cost Of Services CostOfServices	43899000
CY2012Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	139425000	shares
CY2012Q3	us-gaap	Revenues Revenues	731649000
CY2012Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	44156000
CY2012Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3506000
CY2012Q3	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	35222000
CY2012Q3	us-gaap	Gross Profit GrossProfit	569231000
CY2012Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	472710000
CY2012Q3	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	7479000
CY2012Q3	us-gaap	Interest Paid InterestPaid	2766000
CY2012Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6207000
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-9829000
CY2012Q3	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	14702000
CY2012Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4203000
CY2012Q3	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	10415000
CY2012Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2400000
CY2012Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	78485000
CY2012Q3	us-gaap	Interest Expense InterestExpense	8033000
CY2012Q3	us-gaap	Debt Instrument Convertible Interest Expense DebtInstrumentConvertibleInterestExpense	7617000
CY2012Q3	crm	Subscription And Support Revenue SubscriptionAndSupportRevenue	687493000
CY2012Q3	crm	Cost Of Revenue Subscription And Support CostOfRevenueSubscriptionAndSupport	118519000
CY2012Q3	crm	Supplemental Assets Acquired Under Capital Leases SupplementalAssetsAcquiredUnderCapitalLeases	8923000
CY2012Q3	crm	Noncash Or Part Noncash Acquisition Stock Acquired NoncashOrPartNoncashAcquisitionStockAcquired	0
CY2012Q3	crm	Amortization Of Debt Issuance Costs AmortizationOfDebtIssuanceCosts	332000
CY2012Q3	crm	Percentage Of Customer Total Revenue Required To Be Considered Significant Customer PercentageOfCustomerTotalRevenueRequiredToBeConsideredSignificantCustomer	0.05	pure
CY2012Q3	crm	Land Activity And Building Improvements LandActivityAndBuildingImprovements	0
CY2012Q3	crm	Holders Of Notes Conversion Percentage Of Conversion Price HoldersOfNotesConversionPercentageOfConversionPrice	1.30	pure
CY2012Q3	crm	Total Investment Income TotalInvestmentIncome	7173000
CY2012Q3	crm	Number Of Consecutive Trading Days In Period NumberOfConsecutiveTradingDaysInPeriod	30	Day
CY2012Q3	crm	Stock Based Compensation Expense Associated With Cost Of Revenue StockBasedCompensationExpenseAssociatedWithCostOfRevenue	7864000
CY2012Q3	crm	Amortization Of Purchased Intangibles Associated With Cost Of Revenues AmortizationOfPurchasedIntangiblesAssociatedWithCostOfRevenues	17668000
CY2012Q3	crm	Significant Concentration Of Total Revenue Number Customers SignificantConcentrationOfTotalRevenueNumberCustomers	0	pure
CY2012Q3	crm	Number Of Days Out Of Thirty That Common Stock Price Exceeded Conversion Price NumberOfDaysOutOfThirtyThatCommonStockPriceExceededConversionPrice	20	Day
CY2012Q3	crm	Cash Cash Equivalents And Marketable Securities Realized Loss CashCashEquivalentsAndMarketableSecuritiesRealizedLoss	1205000
CY2012Q3	crm	Contractual Interest Expense ContractualInterestExpense	1078000
CY2012Q3	crm	Stock Based Compensation Expense Associated With General And Administrative Expenses StockBasedCompensationExpenseAssociatedWithGeneralAndAdministrativeExpenses	16683000
CY2012Q3	crm	Payments For Investments In Privately Held Companies PaymentsForInvestmentsInPrivatelyHeldCompanies	1129000
CY2012Q3	crm	Stock Based Compensation Expense Associated With Sales And Marketing Expenses StockBasedCompensationExpenseAssociatedWithSalesAndMarketingExpenses	44781000
CY2012Q3	crm	Stock Based Compensation Expense Associated With Research And Development Expenses StockBasedCompensationExpenseAssociatedWithResearchAndDevelopmentExpenses	16089000
CY2012Q3	crm	Amortization Of Purchased Intangibles Associated With Sales And Marketing Expense AmortizationOfPurchasedIntangiblesAssociatedWithSalesAndMarketingExpense	2407000
CY2012Q3	crm	Cash Cash Equivalents And Marketable Securities Realized Gain CashCashEquivalentsAndMarketableSecuritiesRealizedGain	3463000
CY2012Q1	crm	Holders Of Notes Conversion Percentage Of Conversion Price HoldersOfNotesConversionPercentageOfConversionPrice	1.30	pure
CY2012Q1	crm	Number Of Consecutive Trading Days In Period NumberOfConsecutiveTradingDaysInPeriod	30	Day
CY2012Q1	crm	Number Of Days Out Of Thirty That Common Stock Price Exceeded Conversion Price NumberOfDaysOutOfThirtyThatCommonStockPriceExceededConversionPrice	20	Day

Files In Submission

Name	View Source	Status
0001193125-12-377656-index-headers.html	Edgar Link	pending
0001193125-12-377656-index.html	Edgar Link	pending
0001193125-12-377656.txt	Edgar Link	pending
0001193125-12-377656-xbrl.zip	Edgar Link	pending
crm-20120731.xml	Edgar Link	completed
crm-20120731.xsd	Edgar Link	pending
crm-20120731_cal.xml	Edgar Link	unprocessable
crm-20120731_def.xml	Edgar Link	unprocessable
crm-20120731_lab.xml	Edgar Link	unprocessable
crm-20120731_pre.xml	Edgar Link	unprocessable
d378216d10q.htm	Edgar Link	pending
d378216dex311.htm	Edgar Link	pending
d378216dex312.htm	Edgar Link	pending
d378216dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRM
Salesforce, Inc. Stock $crm

2012 Q3 Form 10-Q Financial Statement

#000119312512377656 Filed on August 31, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRM Salesforce, Inc. Stock $crm

2012 Q3 Form 10-Q Financial Statement

#000119312512377656 Filed on August 31, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRM
Salesforce, Inc. Stock $crm